VS PHARMA
ActiveSummary
VS PHARMA has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €720,364 and a net result of €107,287. Equity is growing by about 19% per year across the filed financial years. Its solvency ranks better than 73% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
26-08
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 26 days late
2025
29-08
NBB filing
Annual accounts filed
financial year 2024 · full format · 29 days late
2024
31-12
Financial
Highest result from 2018 to 2025net €221,019 ▲230%
Operating result €304,529, net result €221,019, both a record.
28-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 28 days late
2023
31-12
Financial
Equity above €500,000equity €510,058 ▲15.1%
A profit in every financial year since 2018 builds equity to €510,058.
29-09
NBB filing
Annual accounts filed
financial year 2022 · full format · 60 days late
13-09
Gazette deed
Resignation: PHARMACIE SABRINE ELSEN (manager)Permanent representative: ELSEN Sabrine · Appointment: MANAGEMENT SABRINE ELSEN (director) · Capital conversion12 facts ▸
Gazette deed
Resignation: PHARMACIE SABRINE ELSEN (manager)
Permanent representative: ELSEN Sabrine · Appointment: MANAGEMENT SABRINE ELSEN (director) · Capital conversion12 facts ▸
- General meeting, 07-09-2023
- Other provision, “adoptée à l’unanimité, adaptation des statuts au Code des sociétés et des associations et maintien de la forme SRL” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Other provision, “absence de compte apports non appelés, totalité du capital libérée” (deed in French)
- Other provision, “formes et majorités de la modification des statuts, adoptée à l’unanimité” (deed in French)
- Amendment of the articles
- Capital
- Director resignation, PHARMACIE SABRINE ELSEN (manager)
- Permanent representative, ELSEN Sabrine (2 times)
- Director appointment, MANAGEMENT SABRINE ELSEN (director (not named in the articles))
- Registered office clause, “adoptée à l'unanimité, 4052 Beaufays (Chaudfontaine),Place de la Bouxhe 10” (deed in French)
- Power of attorney
2022
23-08
NBB filing
Annual accounts filed
financial year 2021 · full format · 23 days late
2021
31-08
NBB filing
Annual accounts filed
financial year 2020 · full format · 31 days late
2020
08-10
NBB filing
Annual accounts filed
financial year 2019 · full format · 69 days late
2019
31-12
Financial
Weakest financial yearnet €12,407 ▼81%
Net result drops to €12,407, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
financial year 2018 · full format · 31 days late
2018
31-08
NBB filing
Annual accounts filed
financial year 2017 · full format · 31 days late
2017
31-08
NBB filing
Annual accounts filed
financial year 2016 · full format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 15 annual accounts filed, the latest 10 are here; all 15 are under Financials.
1 of 4 deeds read
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.